Dermira Inc (NASDAQ:DERM) had its price objective upped by Needham & Company LLC from $33.00 to $38.00 in a report released on Friday, Marketbeat.com reports. The firm currently has a “buy” rating on the biopharmaceutical company’s stock. Needham & Company LLC’s price objective would suggest a potential upside of 23.70% from the stock’s previous close. […]
